ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
25.9603
0.04
(0.15%)
At close: 13 December 8:00AM
25.9603
0.00
( 0.00% )
After Hours: 8:15AM

Calls

StrikeBid PriceAsk PriceLast PriceMidpointChangeChange %VolumeOPEN INTLast Trade
22.002.405.700.004.050.000.00 %00-
23.001.404.700.003.050.000.00 %00-
24.000.403.700.002.050.000.00 %00-
25.000.952.600.001.7750.000.00 %00-
26.000.251.500.000.8750.000.00 %00-
27.000.561.350.560.9550.000.00 %00-
28.000.001.350.000.000.000.00 %00-
29.000.001.350.000.000.000.00 %00-
30.000.001.350.000.000.000.00 %00-
31.000.001.350.000.000.000.00 %00-

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Puts

StrikeBid PriceAsk PriceLast PriceMidpointChangeChange %VolumeOPEN INTLast Trade
22.000.001.350.000.000.000.00 %00-
23.000.001.350.000.000.000.00 %00-
24.000.001.350.000.000.000.00 %00-
25.000.000.100.000.000.000.00 %00-
26.000.051.850.050.950.000.00 %01-
27.001.052.900.001.9750.000.00 %00-
28.000.553.900.002.2250.000.00 %00-
29.001.554.900.003.2250.000.00 %00-
30.002.555.900.004.2250.000.00 %00-
31.003.406.900.005.150.000.00 %00-

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TFFPTFF Pharmaceuticals Inc
US$ 0.1049
(61.38%)
7.44M
AVLDirexion Daily AVGO Bull 2X Shares
US$ 29.25
(29.37%)
99.68k
TRUGTruGolf Holdings Inc
US$ 0.6701
(29.14%)
4.93M
SPISPI Energy Company Ltd
US$ 0.4493
(28.37%)
6.21M
AVGXDefiance Daily Target 2X Long AVGO ETF
US$ 27.53
(28.23%)
498.87k
RPTXRepare Therapeutics Inc
US$ 2.53
(-36.27%)
883.55k
INOInovio Pharmaceuticals Inc New
US$ 3.02
(-19.68%)
266.07k
CADLCandel Therapeutics Inc
US$ 7.90
(-19.39%)
1.6M
AVSDirexion Daily AVGO Bear 1X Shares
US$ 21.65
(-13.96%)
17.52k
SLGLSol Gel Technologies Ltd
US$ 0.4436
(-11.26%)
5.02k
AVGOBroadcom Inc
US$ 206.50
(14.30%)
9.7M
TFFPTFF Pharmaceuticals Inc
US$ 0.1049
(61.38%)
7.44M
SPISPI Energy Company Ltd
US$ 0.4493
(28.37%)
6.21M
TRUGTruGolf Holdings Inc
US$ 0.6701
(29.14%)
4.93M
GOEVCanoo Inc
US$ 0.1684
(-3.77%)
4.83M

Discussion

View Full Feed
weedtrader420 weedtrader420 4 minutes ago
You should’ve been a BITCOIN Canadian abstract artist😂👩🏿‍🎨
BTCUSD
cjstocksup cjstocksup 6 minutes ago
https://x.com/elonmusk/status/1867281240459464877
Lifetime Lifetime 6 minutes ago
FFS learned to read a balance sheet. Did any of the idiots take a business class?
Nelson2 Nelson2 7 minutes ago
Appreciate you monitoring and posting
Hopefully next Friday we have the volume
You are looking for

GLTA
BB
cjstocksup cjstocksup 7 minutes ago
https://x.com/elonmusk/status/1867287987039744142
firebag1 firebag1 7 minutes ago
here on this site it said closed at .0017 My TD brokerage closed at .0016 IHUB says .0015
its all over the place but who cares HMBL went up bigly!!
HMBL
Babubd Babubd 7 minutes ago
SOON We Shine! $50+ for diamond hands..imo.
ELAB
Zorax Zorax 8 minutes ago
I read quickly while navigating today that time magazine was going to give shitface the cover? Man of the year? How about crook of the year.
bwrbad bwrbad 8 minutes ago
RxRx M&A: Valence –Cyclica - Exscientia
Valence – a leader in generative AI and deep learning models
Cyclica - a deep learning engine that predicts the polypharmacology of small molecules in drug discovery.
Exscientia - AI-driven precision medicine
RXRX - Regenerative
RXRX
DewDiligence DewDiligence 8 minutes ago
RVNC closed today at a paltry 0.03% discount to Crown's $3.10 buyout price. Given that the cash receipt for shareholders who tender is 1-2 months away and there is some possibility that the tender offer fails, the only logical explanation for the essentially non-existent discount is that the current
RVNC
ka ching ka ching 8 minutes ago
It's going to be a HARBINGER of a year 😂Well at least for Henry and his stealing from shareholders through dilution for Henry and his family thanks All shareholders for their generosity for making his Christmas 🎄🎁 and New year GREAT AGAIN!!!!!
PHIL
Mpphotopro Mpphotopro 8 minutes ago
Starting to get some volume. Anyone know what's up
NGCG
uber darthium uber darthium 8 minutes ago
I haven’t walked the same since
Deportes Deportes 8 minutes ago
Thanks docsetc. Lots of good info
ENZC
weedtrader420 weedtrader420 9 minutes ago
BITCOIN is going to $250,000 probably before February just because where you going to find a bitcoin for sale. i’m not selling. I know about 20 other people that are not selling. Nobody’s selling,only one way ☝️🤑☝️ with all the missing passwords all the bitcoin that’s locked up thrown away.
BTCUSD
dalesio_98 dalesio_98 9 minutes ago
Unless you participated in an IPO, private placement(s), you purchased shares in the secondary market (monies did not go to the company).

Good luck to All!

Shareholders know that shares are liabilities, monies we invest in the company.
cjstocksup cjstocksup 9 minutes ago
https://x.com/elonmusk/status/1867288260722266328
MadScholar1 MadScholar1 9 minutes ago
"A scholar you're not." Ouch! That really hurts, Bruce.

Well, that would make you a propagandist. You're drawing negative attention to one sentence in the comment. I accept your criticism. I could have been clearer.

However, your ad hominum argument -- "lookie here, ov
dstock07734 dstock07734 10 minutes ago
Gary,

The most fundamental difference between the DC vaccine and the others is that NWBO's technology can make dendritic cells load hundreds of tumor-associated antigens on the surface of dendrtic cells while others cannot. That's all. It doesn't matter whatever the name is.
NWBO
cjstocksup cjstocksup 10 minutes ago
https://x.com/WallStreetApes/status/1866244291712168445
Flobewan Flobewan 10 minutes ago
ROTFLMAO
Involuntary-Recluse Involuntary-Recluse 10 minutes ago
Take the night off T, i got the S1 watch tonight ;-)
ASKH
DewDiligence DewDiligence 10 minutes ago
ENTA—I guess you [WorstLuck] are referring to the 40-50 percent odds of approval [per the sell-side analyst report]. This is actually decent for phase 3 in general but definitely low for anti-infectives where pivotal trials historically have fared much better. We have to draw a distinction between d
ENTA
Pokerpro05 Pokerpro05 10 minutes ago
May be safe to say "NEXT YEAR" instead of "NEXT WEEK" in the NEW YEAR 2025

Personally I don't believe anything he says now, and haven't for some time. He will need to actually ACCOMPLISH SOMETHING to me as a share holder other than mouth work to believe/trust anything going forward fr
PHIL
cjstocksup cjstocksup 10 minutes ago
https://x.com/WallStreetApes/status/1866258661477093871

Your Recent History

Delayed Upgrade Clock